Could escitalopram (Lexapro) and trazodone be causing my urinary urgency and frequency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Escitalopram (Lexapro) and Trazodone Cause Urinary Urgency and Frequency?

Yes, escitalopram can cause urinary urgency and frequency, particularly in men with underlying prostatic issues, while trazodone is associated with urinary incontinence rather than urgency symptoms. 1, 2, 3

Escitalopram and Urinary Symptoms

Evidence for Urinary Retention and Voiding Dysfunction

  • Escitalopram has been documented to cause acute urinary retention (AUR) in elderly men with known or latent benign prostatic hyperplasia (BPH). 3
  • Case series demonstrate that AUR developed after introducing escitalopram at standard doses in men with previously diagnosed or unknown/latent BPH, with symptoms resolving after discontinuation. 3, 4
  • A randomized pilot study showed that escitalopram actually increased maximum urinary flow rate (Q_max) in elderly males aged 55-75 years, suggesting it may improve rather than worsen voiding parameters in some patients. 5
  • However, community-based studies found that daily antidepressant use (including SSRIs) was associated with AUASI scores 2-3 points higher than in men not taking these medications, indicating worsened urinary symptoms. 6

Mechanism and Risk Factors

  • The FDA label for escitalopram does not list urinary urgency or frequency as common adverse effects, though it does note that urinary incontinence and urinary retention have been reported post-marketing. 2
  • The risk appears highest in elderly men with compromised or marginal urinary outflow from BPH, where escitalopram may tip the balance toward symptomatic obstruction. 3

Trazodone and Urinary Symptoms

Evidence for Urinary Incontinence

  • The FDA label for trazodone explicitly lists urinary incontinence as a post-marketing adverse reaction, along with urinary retention. 1
  • Trazodone has a low risk of anticholinergic side effects (such as urinary retention, dry mouth, constipation), which distinguishes it from tricyclic antidepressants. 7, 8
  • A systematic review found that antidepressants primarily cause voiding disorders rather than storage symptoms (urgency/frequency), with tricyclics and SNRIs showing higher odds than SSRIs. 9

Clinical Context

  • Trazodone is often prescribed specifically because it avoids many SSRI side effects and has minimal anticholinergic activity. 7, 8
  • The urinary incontinence associated with trazodone appears to be less common than the voiding dysfunction seen with tricyclics or SNRIs. 9

Clinical Algorithm for Your Situation

Step 1: Determine Which Medication is More Likely Responsible

  • If you are male with any degree of prostatic enlargement (even asymptomatic): Escitalopram is the more likely culprit for urgency/frequency symptoms. 3, 6
  • If you experience urinary leakage/incontinence rather than urgency: Trazodone is more likely responsible. 1
  • If you have both urgency AND incontinence: Consider that escitalopram may be causing urgency while trazodone contributes to incontinence. 1, 3

Step 2: Trial Discontinuation Strategy

  • Discontinue escitalopram first if urgency/frequency is the primary complaint, as case reports show symptom resolution within days of stopping. 3, 4
  • Monitor for 4-7 days after discontinuation to assess symptom improvement. 3
  • If symptoms persist after stopping escitalopram, then discontinue trazodone to evaluate its contribution. 1

Step 3: Alternative Medication Selection

  • For depression without urinary symptoms: Consider switching escitalopram to another SSRI, as the urinary effects may be medication-specific rather than class-wide. 5
  • For depression with insomnia: If trazodone must be discontinued, consider that its low-dose use (50-100 mg) for sleep augmentation carries different risk than antidepressant dosing (150-300 mg). 7, 8
  • Avoid tricyclic antidepressants and SNRIs (duloxetine, venlafaxine), as these have higher odds of causing voiding dysfunction than SSRIs. 9

Common Pitfalls to Avoid

  • Do not assume urinary symptoms are solely due to age or prostate disease without considering medication effects, as antidepressants can elevate symptom scores by 2-3 points on validated scales. 6
  • Do not continue both medications while investigating the cause, as this prevents identifying the responsible agent. 3
  • Do not switch to duloxetine or other SNRIs if escitalopram is causing urinary symptoms, as SNRIs have even higher odds of voiding dysfunction. 5, 9
  • Do not overlook that "rare" side effects can still occur in individual patients, particularly when multiple risk factors (age, prostate size, medication combinations) converge. 3, 4

Related Questions

Why does the drug information not list urinary urgency and frequency as a side effect of escitalopram (Lexapro) despite my urologist, primary care physician, and psychiatrist saying it can cause these symptoms?
Can escitalopram (Lexapro) cause urinary frequency?
Can escitalopram (Lexapro) cause urinary urgency, increased frequency, and nocturia in a patient with persistent symptoms despite a normal cystoscopy and no interstitial cystitis?
What are the likely withdrawal symptoms and recommended management for feeling off on the first day after abruptly discontinuing escitalopram (Lexapro) and trazodone?
What is the timeline for developing urinary retention after increasing the dose of Lexapro (escitalopram) by 5mg?
What is the recommended outpatient treatment for a urinary tract infection caused by Group B Streptococcus?
In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma on anastrozole, goserelin, propranolol, escitalopram, and omeprazole who has intermittent eyelid myokymia, occasional lip twitching, a brief knee twitch, and a longstanding leg contour change but no weakness, atrophy, bulbar symptoms, or functional decline, is there any reason to be concerned about amyotrophic lateral sclerosis (ALS)?
How should I manage a patient with hypertension, diabetes mellitus, chronic kidney disease, chronic coronary syndrome, heart failure, prior ischemic stroke, asthma, chronic obstructive pulmonary disease, and dyslipidemia?
What is the best treatment for COVID‑19?
What are the causes of T-wave inversion in leads V2, V3, and V5 in a 62-year-old apparently healthy woman?
In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma on anastrozole, goserelin, propranolol, escitalopram, and omeprazole, who has intermittent eyelid myokymia, occasional lip and knee twitches, chronic leg contour change but no weakness or bulbar signs, are her breathing problems more likely due to obesity rather than amyotrophic lateral sclerosis (ALS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.